Hunan Jingfeng PharmaceuticalLtd Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Xiang Wu Ye
Chief executive officer
CN¥900.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 10yrs |
| CEO ownership | 13.9% |
| Management average tenure | no data |
| Board average tenure | 3.9yrs |
Recent management updates
Recent updates
The Market Doesn't Like What It Sees From Hunan Jingfeng Pharmaceutical Co.,Ltd.'s (SZSE:000908) Revenues Yet As Shares Tumble 27%
Jun 13
Hunan Jingfeng Pharmaceutical Co.,Ltd.'s (SZSE:000908) 31% Dip In Price Shows Sentiment Is Matching Revenues
Apr 16Hunan Jingfeng Pharmaceutical Co.,Ltd.'s (SZSE:000908) 26% Dip In Price Shows Sentiment Is Matching Revenues
Feb 29CEO
Xiang Wu Ye (72 yo)
10yrs
Tenure
CN¥900,000
Compensation
Mr. Xiang Wu Ye serves as General Manager and Chairman of Hunan Jingfeng Pharmaceutical Co., Ltd. and also serves as its Chief Financial Officer. Mr. Ye served as the General Manager of Hunan Tianyi Scienc...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 10yrs | CN¥900.00k | 13.86% CN¥ 597.3m | |
| Board Secretary | 6yrs | CN¥420.00k | 0.035% CN¥ 1.5m | |
| Member of the Supervisory Board | 10yrs | no data | no data | |
| Non-Independent Director | 3.9yrs | no data | no data | |
| Chairman of the Supervisory Board | 3.9yrs | no data | no data | |
| Employee Supervisor | 1.7yrs | no data | 0.000020% CN¥ 862.2 | |
| Non-Independent Director | less than a year | no data | no data | |
| Non-Independent Director | less than a year | no data | no data | |
| Non-Independent Director | less than a year | no data | no data |
3.9yrs
Average Tenure
57yo
Average Age
Experienced Board: 000908's board of directors are considered experienced (3.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 07:04 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hunan Jingfeng Pharmaceutical Co.,Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Guohe Fan | Phillip Securities (HK) |
| Yin Ye | Ping An Securities Co. Ltd. |